Latest filing published 04 Jun 2020 for Ernexa Therapeutics Inc., €21k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 50 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -24.6%Entry US$109,800.00 · Close at T+365 US$82,800.00
- +29.2%Entry US$91,950.00 · Close at T+365 US$118,800.00
- -53.8%Entry US$195,000.00 · Close at T+365 US$90,000.00
- -45.2%Entry US$232,500.00 · Close at T+365 US$127,500.00
- -11.1%Entry US$270,000.00 · Close at T+365 US$240,000.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey Alan Berg: trading record in brief
Jeffrey Alan Berg discloses dealings in Ernexa Therapeutics Inc. to SEC (Form 4). The record holds 74 filings, for trades running from 28 August 2008 to 3 June 2020.
The open-market side counts 56 purchases for €3.4M alongside 9 sales for €143k. Netting one side against the other leaves €3.2M of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants. Since January 2020: no purchases and 7 sales on the market.
A typical purchase (the median) is worth €2,590. None of the 11 purchases we analysed coincided with buying by another insider of the same company within 30 days. For 50 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 44% of cases, with a median move of -2.4%. These figures describe past trades and do not predict future prices.
The newest entry dates from 4 June 2020: an open-market sale of €21k, in Ernexa Therapeutics Inc. The last insider purchase was made public on 16 November 2016, 3,644 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey Alan Berg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,932 shares@ US$1.1015.1% of flowCommon StockSEC:0001493152-20-010545:0
- 30,000 shares@ US$1.05920.0% of flowCommon StockSEC:0001493152-20-010447:0
- 30,730 shares@ US$0.9919.1% of flowCommon StockSEC:0001493152-20-010447:1
- 12,338 shares@ US$1.088.4% of flowCommon StockSEC:0001493152-20-010219:0
- 25,000 shares@ US$1.0616.8% of flowCommon StockSEC:0001493152-20-010219:1
- 20,000 shares@ US$1.0913.9% of flowCommon StockSEC:0001493152-20-010087:0
- 5,000 shares@ US$1.113.5% of flowCommon StockSEC:0001493152-20-010087:1
- 1,700 shares@ US$2.722.9% of flowCommon StockSEC:0001493152-19-019726:0
- 200 shares@ US$2.450.3% of flowCommon StockSEC:0001493152-19-019726:1
- 919 shares0Common StockSEC:0001493152-17-011198:0
- 827 shares0Common StockSEC:0001493152-17-007505:0
- 1,200 shares@ US$7.204.0% of flowCommon StockSEC:0001493152-16-015198:0Canonical exit: 12 Feb 2017 (T+90)
- 500 shares@ US$7.331.7% of flowCommon StockSEC:0001493152-16-015198:1Canonical exit: 13 Feb 2017 (T+90)
- 1,200 shares@ US$7.214.0% of flowCommon StockSEC:0001493152-16-015198:2Canonical exit: 14 Feb 2017 (T+90)
- 1,000 shares@ US$7.233.4% of flowCommon StockSEC:0001493152-16-015198:3Canonical exit: 14 Feb 2017 (T+90)
- 720 shares@ US$7.262.4% of flowCommon StockSEC:0001493152-16-015198:4Canonical exit: 14 Feb 2017 (T+90)
- 500 shares@ US$7.281.7% of flowCommon StockSEC:0001493152-16-015198:5Canonical exit: 14 Feb 2017 (T+90)
- 500 shares@ US$7.251.7% of flowCommon StockSEC:0001493152-16-015198:6Canonical exit: 14 Feb 2017 (T+90)
- 1,000 shares@ US$5.252.4% of flowCommon StockSEC:0001493152-16-012621:0Canonical exit: 10 Nov 2016 (T+90)
- 1,000 shares@ US$5.452.4% of flowCommon StockSEC:0001493152-16-012621:1Canonical exit: 10 Nov 2016 (T+90)
- 1,000 shares@ US$5.342.4% of flowCommon StockSEC:0001493152-16-012621:2Canonical exit: 10 Nov 2016 (T+90)
- 1,000 shares@ US$5.442.4% of flowCommon StockSEC:0001493152-16-012621:3Canonical exit: 10 Nov 2016 (T+90)
- 5,000 shares@ US$0.2738Common StockSEC:0001019687-15-002358:0Canonical exit: 6 Sept 2015 (T+90)
- 5,000 shares@ US$0.2749Common StockSEC:0001019687-15-002358:1Canonical exit: 6 Sept 2015 (T+90)
- 5,000 shares@ US$0.2701Common StockSEC:0001019687-15-002358:2Canonical exit: 6 Sept 2015 (T+90)
25 of 68 declarations
